Breaking Finance News

A report released today by FBR & Co about Metlife Inc (NYSE:MET) ups the target price to $58.00

In a report announced on 5/25/2017 FBR & Co upped the price target of Metlife Inc (NYSE:MET) to $58.00 stating a potential upside of 0.15%.

Boasting a price of $50.52, Metlife Inc (NYSE:MET) traded 0.84% higher on the day. With the last stock price close up 11.25% from the two hundred day average, compared with the S&P 500 Index which has increased 0.02% over the date range. Metlife Inc has recorded a 50-day average of $49.14 and a two hundred day average of $47.66. Volume of trade was down over the average, with 5,112,059 shares of MET changing hands under the typical 5,540,240

Performance Chart

Metlife Inc (NYSE:MET)

With a total market value of $0, Metlife Inc has price-earnings ratio of 623.76 with a one year low of $40.30 and a one year high of $53.27 .

A total of 14 firms have issued a ratings update on Metlife Inc. Five brokers rating the stock a strong buy, 6 brokers rating the stock a buy, six analysts rating the company a hold, zero firms rating the stock a underperform, and finally 0 firms rating the company a sell with a one year target of $49.71.

Brief Synopsis About Metlife Inc (NYSE:MET)

MetLife, Inc. is a provider of life insurance, annuities, employee benefits and asset management. The Company's segments include U.S.; Asia; Latin America; Europe, the Middle East and Africa (EMEA); MetLife Holdings, and Corporate & Other. Its U.S. segment is organized into Group Benefits, Retirement and Income Solutions and Property & Casualty businesses. Its Asia segment offers products, including life insurance; accident and health insurance, and retirement and savings products. Latin America offers products, including life insurance, and retirement and savings products. Life insurance includes universal, variable and term life products. EMEA offers products, including life insurance, accident and health insurance, retirement and savings products, and credit insurance.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.

Leave a Reply

Your email address will not be published. Required fields are marked *